Italia markets closed

Perrigo Company plc (PRGO)

NYSE - Nasdaq Prezzo in tempo reale. Valuta in USD.
Aggiungi a portafoglio
45,86+0,85 (+1,89%)
Alla chiusura: 4:00PM EDT
Accedi per pubblicare un messaggio.
  • s
    stuckinnova
    Teva Pharmaceutical Industries Limited
    News on PRGO
    Perrigo expects thumbs down from FDA on generic ProAir candidate; shares down 1% after hours https://seekingalpha.com/news/3355989?source=ansh $PRGO, $TEVA
    Citing FDA feedback during a teleconference yesterday, Perrigo (NASDAQ:PRGO) expects to receive a Complete Response Letter (CRL) related to its marketing application seeking approval for a gen
    Citing FDA feedback during a teleconference yesterday, Perrigo (NASDAQ:PRGO) expects to receive a Complete Response Letter (CRL) related to its marketing application seeking approval for a gen
    seekingalpha.com
  • S
    Sham
    AcelRx Pharmaceuticals, Inc.
    FDA releases updated industry guidelines for development of generic abuse-deterrent opioid pain meds https://seekingalpha.com/news/3372089?source=ansh $ENDP, $AGN, $JNJ, $TEVA, $MNK, $INSY, $DEPO, $ALKS, $AMPH, $COLL, $EGLT, $PTIE, $ACUR, $PTX, $ACRX, $IPCI, $KMPH, $ELTP, $TRVN, $CXW, $BDSI, $OPNT, $MYL, $PRGO
  • J
    John
    $PRGO conversation
    the previous ceo of this company should be in prison
  • D
    Dave
    $PRGO conversation
    buyout by yearend
  • D
    David
    $PRGO conversation
    starboard should talk directly with mylan and give them a generous offer around 140 150 . I think mylan might consider. Hendrikson hasnt said one optimistic thing ever since he arrived. Thats not an attitude of a confident CEO , only a very catious one. Perrigo cannot continue like this.
  • D
    David
    $PRGO conversation
    I just dont understand all the comotion about drug prices. Perrigos business is not related to this topic. the issue are the serious drugs. most of Perrigos business is oTC stuff so where is the big deal . no one is talking about drug prices for cough syrup.
  • I
    Irina miller
    $PRGO conversation
    80-70-60-50-40-30-20-10-0 Decline has been set and will continue.
    None of these declining steps will hold. Free fall will continue to bankruptcy.
    The current price is way too high. Should be trading less than $30 at this time.
    In one year from now Perrigo will be sub $10 in the next year it will be a penny stock.
    Another thing for sure is this CEO and BOD can not perform.
    Why in the world would anyone one ever invest in this POS run company?
  • D
    David
    $PRGO conversation
    Guys: If we want to see any bounce back of the stock , this requires a complete shake up of management. We need some figures that are appreciated by the street. Current management is just default , nothing special , with no exciting vision except trying to keep the ship from sinking. this is not good enough , we need some drastic and inovative steps. One good CEO can make this change. This is what happened to Teva after the replace the CEO with Erez Vaigman. the share just shot up at once. Hendrikson is not a bad guy , but he doesnt seem to have the vision required to get the ship moving full steam ahead.
  • j
    jeff
    Starboard let's start doing something to increase the value here instead of this steady dropping!
  • D
    David
    $PRGO conversation
    Finally someone is putting this impotent management in its place.
    Its about time someone told them they are incompentant. If you ask me Judy , Hendrikson the whole lot should be replaced . Including the whole board who so willingly rejected the Mylan offer.
    Put some serious guys up who will give us shareholders some value return after such big losses.
  • A
    Anonymous
    $PRGO conversation
    Promius Pharma initiated patent litigation in the U.S. District Court for the Eastern District of Texas, regarding $PRGO 's Paragraph IV ANDA for betamethasone dipropionate, 0.05% spray, asserting patents listed in the Orange Book for Sernivo Spray. Here is the link for more info http://crweworld.com/article/news-provided-by-pr-newswire/307028/perrigo-confirms-patent-challenge-for-generic-version-of-sernivo-spray-005
  • t
    trany
    $PRGO conversation
    David Einhorn, Green light Capital just bought 47.9 Mill worth of Perrigo shares
  • j
    jeff
    $PRGO conversation
    buyout rumor by Teva makes a lot of sense and even a 15 billion offer or 103.00 would be a steal to TEVA. Could be some truth to this!
  • j
    jeff
    $PRGO conversation
    Company has said they are looking to sell royalty stream from their big drug that is on the market. Big stockholder is behind this as well, Since major holder has been buying more and has been quiet on board seat, i'd suspect they know company will soon announce the sale for around 3 billion to royalty buying company or big pharma.
  • L
    L.R.
    Accounting issues and CFO let go. This is terrible news and I predict 10 to 20 percent price drop tomorrow. This is very disturbing news.
  • j
    jeff
    $PRGO conversation
    PRGO due for some news on Starwood increasing ownership and putting more pressure on management to divest divisions and get stock up to 150+. Sale of royalty rights for around 3 billion will get the ball rolling soon.
  • J
    John
    $PRGO conversation
    Well, the combination of the CEO saying generics could not easily be separated from the business, along with the crash in generic drug manufacturer's stocks after the report that DOJ is going to charge generic companies with price collusion, means any chance of a buyout has pretty much vanished.
    The question is if this is an overreaction, and PRGO perhaps won't be as hurt as other generics because of its OTC business...
    http://www.investors.com/news/technology/generic-drugmakers-crash-on-report-doj-plans-collusion-charges/?yptr=yahoo
    Generic-Drug Makers Crash On Report DOJ Plans Collusion Charges
    Generic drug stocks crashed on a report that the Justice Department will soon file charges regarding drug price collusion.
    www.investors.com
  • k
    karlg
    $PRGO conversation
    why is no one talking about the potential buyout of PRGo be RB, PG, JNJ or private equity firms?? It was in the news a few days ago again
  • j
    jeff
    $PRGO conversation
    Interview with Starwood group backs that management is actively looking to sell the royalty stream off for around 3 billion and is not unopposed to selling off drug division too, leaving the company a over the counter product company like JNJ. Likely even that part will get bought out by bigger player. Should hear the beginning of this soon.
  • j
    jeff
    Finally the start to breaking up. First to go royalty interest!